Cargando…
Unintended drug exposure during pregnancy in clinical trials – a survey in early drug development
Purpose: To collect information on unintended drug exposure during pregnancy in early clinical drug development. Materials and methods: Questionnaire mailed in autumn 2015 to members of human pharmacology societies in Europe for anonymous responses via the online tool SurveyMonkey. Results: 53 of th...
Autores principales: | Erb-Zohar, Katharina, Sourgens, Hildegard, Breithaupt-Groegler, Kerstin, Klipping, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737523/ https://www.ncbi.nlm.nih.gov/pubmed/33141016 http://dx.doi.org/10.5414/CP203788 |
Ejemplares similares
-
Use of integrated clinical trial protocols – A survey in early medicines development
por: Erb-Zohar, Katharina, et al.
Publicado: (2018) -
How to Interpret an Investigator’s Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum
por: Rengelshausen, Jens, et al.
Publicado: (2021) -
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
por: Breithaupt-Groegler, Kerstin, et al.
Publicado: (2017) -
The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum
por: Breithaupt-Grögler, Kerstin, et al.
Publicado: (2019) -
EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
por: Van Bortel, Luc, et al.
Publicado: (2018)